|
San Antonio, TX -- March 2, 2018 -- InvestorsHub
NewsWire -- Alternate Health Corp
("Alternate Health" or the "Company") (CSE:AHG)
(OTCQB:AHGIF),
an international corporation that provides software solutions for
the medical cannabis industry, today announced that the Company has
entered into a software-as-a-service agreement with MedMen, one of
the largest cannabis companies in the U.S., to provide e-commerce
and digital payment services. Alternate Health's StatePass system
will begin beta testing with MedMen in their New York
dispensaries.
"We are very pleased to be working with MedMen as Alternate
Health expands into another key state in the U.S. market," said Dr.
Michael Murphy, Chairman and CEO of Alternate Health. "The
implementation of CanaPass in Canada as well as beta testing in
Florida have seen overwhelmingly positive response from our
customers and we look forward to serving the medical cannabis
community in New York with our state-of-the-art system."
The StatePass system is a cloud-based software platform that
manages the end-to-end transactions involved in providing safe
access to medical cannabis to eligible patients. The database is
accessible by the patient, certified doctors and licensed
dispensaries, linked through a seamless interface, and is used to
monitor the individual patient and provide enhanced treatment
recommendations, with a focus on improving patient outcomes.
"Alternate Health's agreement with MedMen is perfectly aligned
with our goal of bringing best-in-class software solutions to the
medical cannabis market," said Jay Briggs, Vice President of
Operations of Alternate Health. "This is an exciting opportunity to
work side-by-side with another leading company in the cannabis
industry and open up new revenue streams in New York's tremendously
promising market."
About MedMen
MedMen is headquartered in Culver City, California and operates
dispensaries and production facilities in three states, including
their soon to open flagship location on Fifth Avenue in Manhattan,
NY. MedMen has been recognized as a leader in the cannabis industry
and recently announced their intention to go public, with a listing
on the Canadian Securities Exchange planned for the second quarter
of 2018.
About StatePass
StatePass is the U.S. equivalent of Alternate Health's
cornerstone CanaPass Cannabis Compliance technology. Alternate
Health's CanaPass system is currently live nationwide in Canada
through a partnership with National Access Cannabis ('NAC'),
Canada's largest chain of medical cannabis clinics. Listed on the
TSX Venture Exchange, NAC is currently expanding into recreational
markets. CanaPass will launch its recreational adaptation in all
future NAC recreational locations. Alternate Health's agreement
with MedMen to use StatePass is based on a fee calculated as a
percent of total transactions made in the system and has been
established for an initial period of 6 months with an automatic
renewal period of 1 year unless either party opts to terminate.
About Alternate Health Corp.
Alternate Health Corp. (CSE: AHG, OTCQB: AHGIF) Alternate Health
has established multiple arms-length operations within the medical
cannabis industry, each of which drives consumers, data and
strategic opportunities to the company's other verticals. This
sophisticated cross-integration of the company's enterprises has
positioned Alternate Health as one of the only cannabis companies
that delivers consistent revenue and intellectual property without
growing, manufacturing or distributing the cannabis plant. Through
its software solutions, data analytics, and patented delivery
systems, Alternate Health's goal is to be the global authority on
scientific and clinical support for cannabis in regulated markets.
Alternate Health is well positioned to reinvest internal operating
cash flow in its platform over the long term, creating an
attractive investment profile for its shareholders.
Alternate Health resides in the cannabis sector along with
companies like GW Pharmaceuticals, AXIM Biotechnologies Inc.,
Canopy Growth Corporation, and Aphria Inc. Alternate Health is
differentiated from other cannabis companies by its focus on
ancillary services for patients, healthcare professionals and
regulatory providers rather than selling a commodity. For more
information about Alternate Health Corp., visit www.alternatehealth.ca.
Neither the CSE nor its Regulation Services Provider (as
that term is defined in the policies of the CSE) accepts
responsibility for the adequacy or accuracy of this release.
Statements included in this announcement, including statements
concerning our plans, intentions and expectations, which are not
historical in nature are intended to be, and are hereby identified
as "forward-looking statements". Forward-looking statements may be
identified by words including "anticipates", "believes", "intends",
"estimates", "expects" and similar expressions. The Company
cautions readers that forward-looking statements, including without
limitation those relating to the Company's future operations,
business prospects and financing plans, are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those indicated in the forward looking
statements.
Investor Relations Contact: Nancy Goertzen, CPIR,
1.604.512.7122, n.goertzen@alternatehealth.ca
|
